Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Generation Bio Co
GBIO | US
2.24
USD-0.02
-0.88%
GBIO | US
About Generation Bio Co
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
21/10/2024
Close
2.24
Open
2.30
High
2.31
Low
2.22
Generation Bio Co. a genetic medicines company develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle central nervous system and oncology. The company was formerly known as Torus Therapeutics Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge Massachusetts.
View LessGBIO | US
Risk
73.2
Sharpe
-0.29
Luna's Score
37/100
Recommendation
Sell
Luna says (GBIO | US)
What's Working
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
67.8%1 month
73.2%3 months
102.7%6 months
107.7%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
1.34
Debt to equity
0.81
Debt to assets
0.35
Ent. to EBITDA
-0.34
Ent. to rev.
2.37
PEG
-
Other Fundamentals
EBITDA
-106.70M
MarketCap
149.50M
MarketCap(USD)
149.50M
Div. yield
-
Op. margin
-530.73
Erngs. growth
-
Rev. growth
364.90
Ret. on equity
-85.71
Short ratio
16.40
Short perc.
5.02
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
0.32
Range1M
0.69
Range3M
1.52
Volumes: Market Activity
Rel. volume
0.87
Price X volume
194.75K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.34 | - | Cheaper |
| Ent. to Revenue | 2.37 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 1.34 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 102.72 | - | Riskier |
| Debt to Equity | 0.81 | -1.23 | Expensive |
| Debt to Assets | 0.35 | 0.25 | Expensive |
| Market Cap | 149.50M | - | Emerging |
